Latest Posts
About This Stock
More About This Stock
Read
Read
Read
E Exact Sciences Is Going Higher
Article By:
Quad 7 Capital
Tuesday, July 30, 2019 12:23 PM EST
With the merger of Exact Sciences and Genomic Health, investors should be looking for EXAS earnings positive results by the end of 2020. In the meantime, revenue growth continues to be astounding.
Triple Play Acquiring Triple Play
Article By:
Bespoke Investment Group
Monday, July 29, 2019 1:14 PM EST
Exact Sciences announced plans today to acquire another health care company, Genomic Health. The two announced that the agreement would combine Exact Sciences with Genomic Health for $72 per share in cash and stock.
Stocks For You To Swing-Trade: EXAS, UNM, ROKU
Article By:
Ryan Mallory
Wednesday, April 17, 2019 7:35 AM EST
Take a look at three trading ideas to prep you for the next trading session.
Exact Sciences: Poised For Further Growth
Great article! Analyst consensus = strong buy with $90 price target. $PFE $EXAS
Exact Sciences: Poised For Further Growth
Article is a good summary and is likely representative of the future for $EXAS.